Partners

Our International Network of Partners

Meeting our ambitious goals will not be possible without the committed engagement of our many partners across Alberta, Canada and the World. We are extremely grateful.

map

Medical Institutions

Prostate Cancer Centre (Calgary)

Northern Alberta Urology Centre (Edmonton)

Alberta Health Services (Alberta)

Vancouver Prostate Cancer Centre (Vancouver)

The Prostate Centre at The Princess Margaret Hospital (Toronto)

CHUM Groupe de soutien du cancer de la prostate (Montreal)

London Regional Cancer Program (London, ON)

Technology Platforms

Malvern (UK)

APOGEE (UK)

Nanosight

BGI Genomics (China)

Precision Nanosystems (BC)

Universities

University of Alberta (Edmonton, AB)

University of Calgary (Calgary, AB)

Western University (London, ON)

Dalhousie University (Halifax, NS)

University of Toronto (Toronto, ON)

Vanderbilt University (Nashville, TN)

Case Western Reserve University (Cleveland, OH)

Fraunhofer ITEM-R (Regensburg, Germany)

Biorepositories

Alberta Cancer Research Biobank (Calgary, Edmonton)

Australian Prostate Cancer BioResource (Australia: Melbourne, Sydney, Brisbane and Adelaide)

OICR Tumour Bank (Ontario)

Tomorrow Project 

UHN GU BioBank

Canadian Biosample Repository

Canadian Prostate Cancer Biomarker Network

Financial Resources

Alberta Cancer Foundation (Alberta)

Movember Foundation (Australia, Canada)

Terry Fox Research Institute (Canada)

Motorcycle Ride for Dad (Canada)

Prostate Cancer Canada

Alberta Innovates Health Solutions – Collaborative Research and Innovation opportunities

Alberta Lymphedema Network (Edmonton, Alberta)

University Hospital Foundation – J & J Partnership

Support Groups

Prostate Cancer Canada Network (Canada)

Prostate Cancer Canada Network (Calgary)

Prostate Cancer Canada Network (Edmonton)

Business Partners

Nanostics

APCaRI is part of the Movember Prostate Cancer Outcomes network

The Prostate Cancer Outcomes Global Initiative to Compare and Reduce Variation is a project led by Movember aiming to improve health outcomes for men throughout their prostate cancer journey by focusing on variation in care and engaging clinicians and researchers across 14 countries worldwide.

The international team will collect data from prostate cancer patients segmented into the categories of data items as outlined by the International Consortium for Health Outcomes Measurement (ICHOM). These include patient factors, baseline tumor factors, pathological information, treatment variables, acute complications of treatment, and survival and disease control).

The Alberta Prostate Cancer dataset is highly aligned with the ICHOM standards. This means that we can effectively compare treatments and outcomes in Alberta with teams around the world to find ways to improve our care at home and abroad!

This is the result of hours of planning and true team work lead by Dr. Trafford Crump, the APCaRI Scientific and Data Quality Committee, and the APCaRI clinical, scientific, research and pathology teams. Thanks to your efforts, we are one step closer to improving patient outcomes.

- John Lewis